Evaluation of the Efficacy Safety and Tolerability of Nitric Oxide Given Intermittently Via Inhalation to Subjects With Bronchiolitis
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Bronchiolitis
- Focus Registrational; Therapeutic Use
- Acronyms NO-BRO
- Sponsors AIT
- 19 Mar 2018 According to an AIT Therapeutics Inc. media release, company anticipated to complete enrollment in April 2018 and top-line data from this trial is expected in second quarter of 2018 .
- 16 Feb 2018 According to an AIT Therapeutics Inc. media release, top-line data from the study is expected in the second quarter of 2018.
- 19 Dec 2017 Status changed from active, no longer recruiting to recruiting.